Inari Medical, Inc. (NARI)
NASDAQ: NARI · Real-Time Price · USD
79.55
+0.15 (0.19%)
At close: Jan 17, 2025, 4:00 PM
79.41
-0.14 (-0.18%)
After-hours: Jan 17, 2025, 6:18 PM EST

Company Description

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States.

The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation.

It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013.

Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Inari Medical, Inc.
Inari Medical logo
Country United States
Founded 2011
IPO Date May 22, 2020
Industry Medical Devices
Sector Healthcare
Employees 1,300
CEO Andrew Hykes

Contact Details

Address:
6001 Oak Canyon, Suite 100
Irvine, California 92618
United States
Phone 877 923 4747
Website inarimedical.com

Stock Details

Ticker Symbol NARI
Exchange NASDAQ
Stock Type Common Stock
Fiscal Year January - December
Reporting Currency USD
IPO Price $19.00
CIK Code 0001531048
CUSIP Number 45332Y109
ISIN Number US45332Y1091
Employer ID 45-2902923
SIC Code 3841

Key Executives

Name Position
Andrew J. Hykes Chief Executive Officer, President and Director
Dr. Thomas M. Tu M.D. Chief Medical Officer
Kevin Strange Chief Financial Officer
Paul A. Koehn Senior Vice President of Operations
Karen Silva Vice President of Finance and Accounting
Hussain Rangwala Chief Technology Officer
Neil Bhalodkar Vice President of Investor Relations
Shannon Trevino General Counsel and Corporate Secretary
Eric Khairy Senior Vice President of Marketing
Tara Dunn Senior Vice President and GM of LimFlow

Latest SEC Filings

Date Type Title
Jan 17, 2025 SC 14D9 Filing
Jan 17, 2025 SC TO-T Filing
Jan 15, 2025 SC14D9C Filing
Jan 7, 2025 SC14D9C Filing
Jan 7, 2025 SC TO-C Filing
Jan 7, 2025 SC TO-C Filing
Jan 6, 2025 SC14D9C Filing
Jan 6, 2025 8-K Current Report
Jan 6, 2025 144 Filing
Dec 12, 2024 144 Filing